BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11106814)

  • 1. TEL/AML-1 fusion gene. its frequency and prognostic significance in childhood acute lymphoblastic leukemia.
    Jamil A; Theil KS; Kahwash S; Ruymann FB; Klopfenstein KJ
    Cancer Genet Cytogenet; 2000 Oct; 122(2):73-8. PubMed ID: 11106814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study.
    Mosad E; Hamed HB; Bakry RM; Ezz-Eldin AM; Khalifa NM
    J Hematol Oncol; 2008 Oct; 1():17. PubMed ID: 18928518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Münster Study Group.
    Seeger K; Adams HP; Buchwald D; Beyermann B; Kremens B; Niemeyer C; Ritter J; Schwabe D; Harms D; Schrappe M; Henze G
    Blood; 1998 Mar; 91(5):1716-22. PubMed ID: 9473238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia.
    Martínez-Ramírez A; Urioste M; Contra T; Cantalejo A; Tavares A; Portero JA; López-Ibor B; Bernacer M; Soto C; Cigudosa JC; Benítez J
    Haematologica; 2001 Dec; 86(12):1245-53. PubMed ID: 11726315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study Group.
    Borkhardt A; Cazzaniga G; Viehmann S; Valsecchi MG; Ludwig WD; Burci L; Mangioni S; Schrappe M; Riehm H; Lampert F; Basso G; Masera G; Harbott J; Biondi A
    Blood; 1997 Jul; 90(2):571-7. PubMed ID: 9226156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia.
    McLean TW; Ringold S; Neuberg D; Stegmaier K; Tantravahi R; Ritz J; Koeffler HP; Takeuchi S; Janssen JW; Seriu T; Bartram CR; Sallan SE; Gilliland DG; Golub TR
    Blood; 1996 Dec; 88(11):4252-8. PubMed ID: 8943861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss at 12p detected by comparative genomic hybridization (CGH): association with TEL-AML1 fusion and favorable prognostic features in childhood acute lymphoblastic leukemia (ALL). A multi-institutional study.
    Kanerva J; Niini T; Vettenranta K; Riikonen P; Mäkipernaa A; Karhu R; Knuutila S; Saarinen-Pihkala UM
    Med Pediatr Oncol; 2001 Nov; 37(5):419-25. PubMed ID: 11745869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low incidence of TEL/AML1 fusion and TEL deletion in Korean childhood acute leukemia by extra-signal fluorescence in situ hybridization.
    Park KU; She CJ; Shin HY; Ahn HS; Kim CJ; Cho BK; Cho HI; Lee DS
    Cancer Genet Cytogenet; 2001 Apr; 126(1):73-7. PubMed ID: 11343784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of TEL/AML1 fusion transcript in childhood B-precursor acute lymphoblastic leukemia.
    Takahashi Y; Horibe K; Kiyoi H; Miyashita Y; Fukuda M; Mori H; Nozaki C; Hasegawa S; Kawabe T; Kato K; Kojima S; Matuyama T; Naoe T
    J Pediatr Hematol Oncol; 1998; 20(3):190-5. PubMed ID: 9628428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the efficacy of two chemotherapy protocols for children with TEL-AML1[STBZ] fusion gene positive acute lymphoblastic leukemia].
    Wang KL; Mei YY; Cui L; Gao C; Liu FF; Zhao XX; Li WJ; Jiang J; Zhang RD; Xie J; Shi HW; Wang B; Zhang YH; Ma XL; Wu MY; Zhou X; Li ZG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):285-90. PubMed ID: 24762993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia.
    Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S
    Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of TEL/AML1 fusion gene in Brazilian pediatric patients with acute lymphoblastic leukemia.
    Zen PR; Lima MC; Coser VM; Silla L; Daudt L; Fernandes MS; Neumann J; Mattevi MS; Ortigara R; Paskulin GA
    Cancer Genet Cytogenet; 2004 May; 151(1):68-72. PubMed ID: 15120912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.
    Peter A; Heiden T; Taube T; Körner G; Seeger K
    Eur J Haematol; 2009 Nov; 83(5):420-32. PubMed ID: 19594616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
    Madzo J; Zuna J; Muzíková K; Kalinová M; Krejcí O; Hrusák O; Otová B; Starý J; Trka J
    Cancer; 2003 Jan; 97(1):105-13. PubMed ID: 12491511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of the childhood acute lymphoblastic leukemia with t(12;21)].
    Lin D; Liu SH; Zhu XF; Bo LJ; Li CW; Chen YM; Liu XP; Qin S; Dai Y; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):17-21. PubMed ID: 14990071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable outcome in 20-year follow-up of children with very-low-risk ALL and minimal standard therapy, with special reference to TEL-AML1 fusion.
    Kanerva J; Saarinen-Pihkala UM; Niini T; Riikonen P; Möttönen M; Mäkipernaa A; Salmi TT; Vettenranta K; Knuutila S
    Pediatr Blood Cancer; 2004 Jan; 42(1):30-5. PubMed ID: 14752791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of TEL-AML1 transcript in acute lymphoblastic leukemia in long-term remission.
    Endo C; Oda M; Nishiuchi R; Seino Y
    Pediatr Int; 2003 Jun; 45(3):275-80. PubMed ID: 12828580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance.
    Rubnitz JE; Downing JR; Pui CH; Shurtleff SA; Raimondi SC; Evans WE; Head DR; Crist WM; Rivera GK; Hancock ML; Boyett JM; Buijs A; Grosveld G; Behm FG
    J Clin Oncol; 1997 Mar; 15(3):1150-7. PubMed ID: 9060558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TEL/AML1 rearrangement and the prognostic significance in childhood acute lymphoblastic leukemia in Hong Kong.
    Tsang KS; Li CK; Chik KW; Shing MM; Tsoi WC; Ng MH; Lau TT; Leung Y; Yuen PM
    Am J Hematol; 2001 Oct; 68(2):91-8. PubMed ID: 11559948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translocation (2;8)(p12;q24) associated with a cryptic t(12;21)(p13;q22) TEL/AML1 gene rearrangement in a child with acute lymphoblastic leukemia.
    Loh ML; Samson Y; Motte E; Moreau LA; Dalton V; Waters S; Sallan SE; Gilliland DG
    Cancer Genet Cytogenet; 2000 Oct; 122(2):79-82. PubMed ID: 11106815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.